Catalyst Event
Natera Inc (NTRA) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
3/16/2026, 12:00:00 AM
Announced the publication of two peer-reviewed studies on March 16, 2026, highlighting the clinical utility of its Signatera test in anal and rectal cancers, showing positive results for predicting survival and recurrence.
Korean Translation
2026년 3월 16일, 항문암 및 직장암에서 Signatera 테스트의 임상적 유용성을 강조하는 두 건의 동료 심사 연구 발표. 생존 및 재발 예측에 긍정적인 결과를 보임.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Baidu Inc (BIDU) · Earnings Release
Q1 2026 earnings release is scheduled for May 20, 2026. Medium importance is estimated as quarterly earnings typically result in price movements exceeding 5%.
5/20/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
Fortinet Inc (FTNT) · Earnings Release
Fortinet is expected to release its Q1 2026 earnings report on April 30, 2026, with analysts forecasting EPS of $0.62 and revenue of $1.73B, scheduled.
4/30/2026, 12:00:00 AM
Automatic Data Processing Inc (ADP) · Earnings Release
Automatic Data Processing is estimated to report its Q3 2026 earnings on or around April 29, 2026, based on past reporting schedules. As earnings reports typically trigger price movements of 5-10%, importance is estimated as Medium, scheduled.
4/29/2026, 12:00:00 AM